Evidence mapPaperPMID 37995334Full record

SynthesisAmerican journal of hypertension2024

The Relevance of Arterial Blood Pressure in the Management of Glaucoma Progression: A Systematic Review.

Jan Van Eijgen, Jesus D Melgarejo, Jana Van Laeken, Claire Van der Pluijm, Hanne Matheussen, Micheline Verhaegen, Karel Van Keer, Gladys E Maestre, Lama A Al-Aswad, Thomas Vanassche and 2 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in American journal of hypertension, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Jan Van EijgenDepartment of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium.ORCID 0000-0001-7243-9280
Jesus D MelgarejoInstitute of Neurosciences, School of Medicine, University of Texas Rio Grande Valley, Harlingen, Texas, USA.
Jana Van LaekenDepartment of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium.
Claire Van der PluijmResearch Group Ophthalmology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Hanne MatheussenResearch Group Ophthalmology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Micheline VerhaegenDepartment of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium.
Karel Van KeerResearch Group Ophthalmology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Gladys E MaestreInstitute of Neurosciences, School of Medicine, University of Texas Rio Grande Valley, Harlingen, Texas, USA.
Lama A Al-AswadDepartment of Ophthalmology, New York University (NYU) School of Medicine, NYU Langone Health, New York, USA.
Thomas VanasscheCentre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Zhen-Yu ZhangResearch Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, KU Leuven , Leuven, Belgium.
Ingeborg StalmansDepartment of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium.
KU Leuven · BEUniversitair Ziekenhuis Leuven · BEThe University of Texas Rio Grande Valley · USNYU Langone Health · US

Funding

South Texas Alzheimer's Disease Center Research and Education CoreP30AG066546 · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 2025 to 2025
$2.9M
NEI NIH HHS R21 EY029605NIA NIH HHS P30 AG059305NIA NIH HHS P30 AG066546
6 · The paper itself

Abstract

backgroundGlaucoma is one of the leading causes of global blindness and is expected to co-occur more frequently with vascular morbidities in the upcoming years, as both are aging-related diseases. Yet, the pathogenesis of glaucoma is not entirely elucidated and the interplay between intraocular pressure, arterial blood pressure (BP) and ocular perfusion pressure is poorly understood.

objectivesThis systematic review aims to provide clinicians with the latest literature regarding the management of arterial BP in glaucoma patients.

methodsA systematic search was performed in Medline, Embase, Web of Science and Cochrane Library. Articles written in English assessing the influence of arterial BP and systemic antihypertensive treatment of glaucoma and its management were eligible for inclusion. Additional studies were identified by revising references included in selected articles.

results80 Articles were included in this systemic review. A bimodal relation between BP and glaucoma progression was found. Both high and low BP increase the risk of glaucoma. Glaucoma progression was, possibly via ocular perfusion pressure variation, strongly associated with nocturnal dipping and high variability in the BP over 24 h.

conclusionsWe concluded that systemic BP level associates with glaucomatous damage and provided recommendations for the management and study of arterial BP in glaucoma. Prospective clinical trials are needed to further support these recommendations.

Indexed as

Antihypertensive AgentsArterial PressureDisease ProgressionGlaucomaIntraocular PressureHumansHypertensionRisk FactorsAntihypertensive Agents24-h ABPMblood pressureblood pressure variabilityglaucomahypertensionnocturnal dipping

Identifiers

PMID37995334
PMCPMC10906067
OpenAlexW4388928462

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.